{"name":"Sichuan Clover Biopharmaceuticals, Inc.","slug":"sichuan-clover-biopharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"Sichuan Clover Biopharmaceuticals, Inc. is a biotechnology company focused on the research and development of innovative therapeutic proteins and vaccines. The company has a pipeline that includes a phase 1 candidate for a recombinant human tumor necrosis factor receptor II -Fc-TPO mimetic peptide fusion protein.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQRzEwNDYyZlhlTVY1VzU1ZjEzZjNUSF9raW1WZnJBNE1tUnZzTzNnbUx1TnQxWkgtMXk3TUtfdm0yX1Vuc2wtNHUwT0lIVmxUQ1c5V1Item9vMFhTQ01jS2tZOVM4V24zRndWVWxFekhuS3hZV21OR3g2d1J0WV9uSF9qSUlOMEUzUExiSy1BUng3T0Y5NEVYN3hCV2F5UUd5NUE?oc=5","date":"2025-03-24","type":"regulatory","source":"Fierce Pharma","summary":"Gavi terminates COVID vaccine deal with Clover, demands $224M repayment - Fierce Pharma","headline":"Gavi terminates COVID vaccine deal with Clover, demands $224M repayment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNUV9lWmtWWVRSWVB3R254VnFzRXBULUdoVloyQjBvTm9Ga1ZXQlloQ3pQOHYzMEw1b3EtSU9rR1dlTnp0dHlfNjdzdUZkQmNyQVl2S3pfc205QnFxM3Z5TXQtU2pSNWp2cWNhT1doT3pMemxINWhIY3RnQ1VVd1hueG9R?oc=5","date":"2021-11-09","type":"pipeline","source":"BioWorld News","summary":"Clover raises $260M in Hong Kong IPO - BioWorld News","headline":"Clover raises $260M in Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNb0VIejhfNUc2ZlV0Y3NjbjBKQXJYTy05WXdHSmJ2bklJRm9Fcm04emhPTDI2ZU1QX3lXOVpGb1FqNlgtblo5UmVZMkZmSmY5LWZLdENMWkVhRTl5aXdudHg1cTUwY19QSlhhMGNQWktLOWpSS3FlX1BLZk5OUW1JcA?oc=5","date":"2021-11-05","type":"pipeline","source":"BioWorld News","summary":"Airdoc stumbles with Hong Kong IPO - BioWorld News","headline":"Airdoc stumbles with Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2020-12-11","type":"trial","source":"Philstar.com","summary":"AstraZeneca backs out of planned vaccine trials in the Philippines - Philstar.com","headline":"AstraZeneca backs out of planned vaccine trials in the Philippines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNbXpkUHJoT2JXTUJLak5NQUM5cUV4MFdFcS03d1o3NU5NallhVGF5UHRhUUdxYmFwaWNaSGQ4MkpKMnV4LUVjYVRtOWRnMWxsUTh2cjBidWlaaVNuSmxGRWt2MEs0YVQ0U1VnSVRtTFdQbHg3eThRMEVGby1UY1V1VjJueXNVSWNlYk9ycTRtU2hyQzFUckVFVF9OZ1Z6SjhaenJKYkJJU2ZaOU5tb3RTLQ?oc=5","date":"2020-07-06","type":"deal","source":"CEPI","summary":"CEPI expands partnership with Clover Biopharmaceuticals to rapidly advance development and manufacture of COVID-19 vaccine candidate - CEPI","headline":"CEPI expands partnership with Clover Biopharmaceuticals to rapidly advance development and manufacture of COVID-19 vacci","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQajMxT1g5UWtQQW5LUExaY1FHQ3FOVXpkTnlHbC1PNVpRUXRjbHRYM0pxQjVVa2ZobzN4QmROTENIM3IzaVEta0ViY19uWERCVmd6ZGlveWhtbHFvWThiZjNLUFFMWWVJbVdBb3NxSnc0cHJHd3BIa0VGWUFNTi1lck1QRllETElYLVZpZUlfalo3SFVDVXc0X0pXRUZYZS16UVg5WlVPbUU0cGpKSnc?oc=5","date":"2020-04-26","type":"deal","source":"CEPI","summary":"CEPI announces COVID-19 vaccine development partnership with Clover Biopharmaceuticals' Australian Subsidiary - CEPI","headline":"CEPI announces COVID-19 vaccine development partnership with Clover Biopharmaceuticals' Australian Subsidiary","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}